Front Row Advisors’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-19
| Closed | -$2K | – | 999 |
|
|
2021
Q1 | $2K | Hold |
19
| – | – | ﹤0.01% | 894 |
|
|
2020
Q4 | $1K | Hold |
19
| – | – | ﹤0.01% | 905 |
|
|
2020
Q3 | $1K | Hold |
19
| – | – | ﹤0.01% | 902 |
|
|
2020
Q2 | $1K | Hold |
19
| – | – | ﹤0.01% | 971 |
|
|
2020
Q1 | $1K | Hold |
19
| – | – | ﹤0.01% | 953 |
|
|
2019
Q4 | $1K | Hold |
19
| – | – | ﹤0.01% | 896 |
|
|
2019
Q3 | $1K | Hold |
19
| – | – | ﹤0.01% | 903 |
|
|
2019
Q2 | $2K | Hold |
19
| – | – | ﹤0.01% | 895 |
|
|
2019
Q1 | $1K | Hold |
19
| – | – | ﹤0.01% | 1026 |
|
|
2018
Q4 | $1K | Hold |
19
| – | – | ﹤0.01% | 1013 |
|
|
2018
Q3 | $2 | Hold |
19
| – | – | ﹤0.01% | 854 |
|
|
2018
Q2 | $2 | Hold |
19
| – | – | ﹤0.01% | 895 |
|
|
2018
Q1 | $2K | Hold |
19
| – | – | ﹤0.01% | 825 |
|
|
2017
Q4 | $2K | Buy |
+19
| New | +$1.89K | ﹤0.01% | 715 |
|
Front Row Advisors's CMD Position: Q2 2021 in Review
Front Row Advisors sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 19 shares — an estimated $2K sold.
Front Row Advisors first reported a position in CMD in Q4 2017 and held it in 14 quarters. The position peaked at $2K in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Front Row Advisors reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Front Row Advisors sold 19 Cantel Medical Corporation shares in Q2 2021, an estimated $2K.
- Front Row Advisors first reported a position in Cantel Medical Corporation in Q4 2017 and held it in 14 quarters.
- Front Row Advisors's Cantel Medical Corporation position peaked at $2K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Front Row Advisors's 13F filing for Q2 2021, filed 23 Aug 2021.